Literature DB >> 10961905

CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor.

F Tajima1, T Sato, J H Laver, M Ogawa.   

Abstract

Controversy has existed about CD34 expression by hematopoietic stem cells. We recently reported that CD34 expression reflects the activation state of stem cells by using a murine transplantation model. It has been generally held that mobilized blood stem cells express CD34.However, it has also been reported that mobilized stem cells and progenitors are in G0/G1 phases of the cell cycle. To address the state of CD34 expression by the mobilized stem cells, we again used the mouse transplantation model. We prepared CD34(-) and CD34(+) populations of nucleated blood cells from granulocyte colony-stimulating factor-treated Ly-5.1 mice and assayed each population for long-term engrafting cells in lethally irradiated Ly-5.2 mice. The majority of the stem cells were in the CD34(+) population. The CD34 expression by mobilized stem cells was reversible because re-transplantation of Ly-5.1 CD34(-) marrow cells harvested from the Ly-5.2 recipients of CD34(+)-mobilized stem cells 8 months posttransplantation revealed long-term engraftment. These results may support the use of total CD34(+) cells in mobilized blood as a predictor for engraftment and CD34 selection for enrichment of human stem cells. (Blood. 2000;96:1989-1993)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961905

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis.

Authors:  Sebastian George Barton Furness; Kelly McNagny
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Postconditioning attenuates renal ischemia-reperfusion injury by mobilization of stem cells.

Authors:  Xiaohua Tan; Ruili Yin; Yan Chen; Dan Gao; Xiuying Zhang
Journal:  J Nephrol       Date:  2015-02-06       Impact factor: 3.902

3.  Deficiency of Src family kinases compromises the repopulating ability of hematopoietic stem cells.

Authors:  Christie M Orschell; Jovencio Borneo; Veerendra Munugalavadla; Peilin Ma; Emily Sims; Baskar Ramdas; Mervin C Yoder; Reuben Kapur
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

Review 4.  Plasticity of mesenchymal stem cells--regenerative medicine for diseased hearts.

Authors:  Satoshi Gojo; Akihiro Umezawa
Journal:  Hum Cell       Date:  2003-03       Impact factor: 4.174

5.  Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis.

Authors:  Jinpeng Li; Ashwini S Phadnis-Moghe; Robert B Crawford; Norbert E Kaminski
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

6.  Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect.

Authors:  Michelle B Bowie; Kristen D McKnight; David G Kent; Lindsay McCaffrey; Pamela A Hoodless; Connie J Eaves
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

7.  Differential regulation of the human and murine CD34 genes in hematopoietic stem cells.

Authors:  Yutaka Okuno; Hiromi Iwasaki; Claudia S Huettner; Hanna S Radomska; David A Gonzalez; Daniel G Tenen; Koichi Akashi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 8.  Human CD34- hematopoietic stem cells: basic features and clinical relevance.

Authors:  Kiyoshi Ando
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

9.  The endothelial antigen ESAM marks primitive hematopoietic progenitors throughout life in mice.

Authors:  Takafumi Yokota; Kenji Oritani; Stefan Butz; Koichi Kokame; Paul W Kincade; Toshiyuki Miyata; Dietmar Vestweber; Yuzuru Kanakura
Journal:  Blood       Date:  2008-12-18       Impact factor: 22.113

10.  Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment.

Authors:  Carl R Walkley; Jeremy M Shea; Natalie A Sims; Louise E Purton; Stuart H Orkin
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.